Structured assessment and followup for patients with hereditary kidney tumour syndromes | Zendy

JeanBaptiste Lattouf | Zendy; Stephen E. Pautler | Zendy; M. Neil Reaume | Zendy; Raymond H. Kim | Zendy; Melanie Care | Zendy; Jane Green | Zendy; Alan So | Zendy; Philippe D. Violette | Zendy; Issam Saliba | Zendy; Philippe Major | Zendy; Shane Silver | Zendy; Richard Leicht | Zendy; Joan Basiuk | Zendy; Simon Tanguay | Zendy; Michael A.S. Jewett | Zendy; Darrel Drachenberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Structured assessment and followup for patients with hereditary kidney tumour syndromes

Author(s) -

JeanBaptiste Lattouf,

Stephen E. Pautler,

M. Neil Reaume,

Raymond H. Kim,

Melanie Care,

Jane Green,

Alan So,

Philippe D. Violette,

Issam Saliba,

Philippe Major,

Shane Silver,

Richard Leicht,

Joan Basiuk,

Simon Tanguay,

Michael A.S. Jewett,

Darrel Drachenberg

Publication year - 2016

Publication title -

canadian urological association journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.477

H-Index - 38

eISSN - 1920-1214

pISSN - 1911-6470

DOI - 10.5489/cuaj.3798

Subject(s) - medicine , tuberous sclerosis , renal cell carcinoma , leiomyomatosis , kidney cancer , von hippel–lindau disease , pheochromocytoma , disease , oncology , gynecology , surgery , pathology , leiomyoma

Optimal clinical assessment and subsequent followup of patients with or suspected of having a hereditary renal cell carcinoma syndrome (hRCC) is not standardized and practice varies widely. We propose protocols to optimize these processes in patients with hRCC to encourage a more uniform approach to management that can then be evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research